Additionally, the incorporation of TRAIL in iMSC (iMSC-TRAIL) via site-specific integration into ribosomal DNA resulted in inducing apoptosis in melanoma, liver, breast, and lung cancers in vitro and inhibiting tumor growth through the activation of apoptotic pathways in vivo [83]. Here, TNFSF10 is linked to lung carcinoma.